Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Medibank Private ( (AU:MPL) ) has shared an announcement.
Medibank Private Limited has notified the market of the issue of 3,230,852 unquoted performance rights under its employee incentive scheme. These performance rights, which are not intended to be quoted on the ASX, were issued on 12 December 2025 and reflect the company’s ongoing use of equity-based incentives to align employee remuneration with long-term shareholder value.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.05 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is an Australian private health insurance company listed on the ASX under the code MPL. It offers health insurance products and related services to individuals and corporate customers, operating as one of the major players in Australia’s private health insurance market.
Average Trading Volume: 6,062,956
Technical Sentiment Signal: Buy
Current Market Cap: A$13.19B
For detailed information about MPL stock, go to TipRanks’ Stock Analysis page.